Christoph Rudiger Antz

Director & Chief Executive Officer

Director & Chief Executive Officer at Veraxa Biotech AG - Post de-SPAC, filing insider transactions on 2026-08-27.

Total Purchases

$8K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1 total filings

Active Since

2026-08-27

Last: 2026-08-27

Companies

Veraxa Biotech AG - Post de-SPAC

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-27	VRXA	Purchase	5,000	$1.53	$8K	5,000	SEC ↗